Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science. 1996;272:1955–8.

Article  CAS  PubMed  Google Scholar 

Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, Di Marzio P, Marmon S, Sutton RE, Hill CM, et al. Identification of a major co-receptor for primary isolates of HIV-1 [see comments]. Nature. 1996;381:661–6.

Article  CAS  PubMed  Google Scholar 

Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, K.A. N, Cayanan C, Maddon PJ, Koup RA, Moore JP, Paxton WA. HIV-1 entry into CD4 + cells is mediated by the chemokine receptor CC-CKR-5. Nature. 1996;381:667–73.

Article  CAS  PubMed  Google Scholar 

Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor [see comments]. Science. 1996;272:872–7.

Article  CAS  PubMed  Google Scholar 

Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R, MacDonald ME, Stuhlmann H, Koup RA, Landau NR. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell. 1996;86:367–77.

Article  CAS  PubMed  Google Scholar 

Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoeffer S, Nowak MA, Hahn BH. al e: viral dynamics in human immunodeficiency virus type 1 infection. Nature. 1995;373:117–22.

Article  CAS  PubMed  Google Scholar 

Ndung’u T, Lu Y, Renjifo B, Touzjian N, Kushner N, Pena-Cruz V, Novitsky VA, Lee TH, Essex M. Infectious simian/human immunodeficiency virus with human immunodeficiency virus type 1 subtype C from an African isolate: rhesus macaque model. J Virol. 2001;75:11417–25.

Article  PubMed  PubMed Central  Google Scholar 

Ndung’u T, Renjifo B, Essex M. Construction and analysis of an infectious human Immunodeficiency virus type 1 subtype C molecular clone. J Virol. 2001;75:4964–72.

Article  PubMed  PubMed Central  Google Scholar 

Ndung’u T, Renjifo B, Novitsky VA, McLane MF, Gaolekwe S, Essex M. Molecular cloning and biological characterization of full-length HIV-1 subtype C from Botswana. Virology. 2000;278:390–9.

Article  PubMed  Google Scholar 

Koulinska IN, Ndung’u T, Mwakagile D, Msamanga G, Kagoma C, Fawzi W, Essex M, Renjifo B. A new human immunodeficiency virus type 1 circulating recombinant form from Tanzania. AIDS Res Hum Retroviruses. 2001;17:423–31.

Article  CAS  PubMed  Google Scholar 

Montano MA, Nixon CP, Ndung’u T, Bussmann H, Novitsky VA, Dickman D, Essex M. Elevated tumor necrosis factor-alpha activation of human immunodeficiency virus type 1 subtype C in Southern Africa is associated with an NF-kappaB enhancer gain-of-function. J Infect Dis. 2000;181:76–81.

Article  CAS  PubMed  Google Scholar 

Novitsky V, Montano M, McLane M, Renjifo B, Vannberg F, Foley B, Ndung’u T, Rahman M, Makhema M, Marlink R, Essex M. Molecular cloning and phylogenetic analysis of human immunodeficiency virus type 1 subtype C: a set of 23 full-length clones from Botswana. J Virol. 1999;73:4427–32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Novitsky V, Smith UR, Gilbert P, McLane MF, Chigwedere P, Williamson C, Ndung’u T, Klein I, Chang SY, Peter T, et al. Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design? J Virol. 2002;76:5435–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Doualla-Bell F, Gaseitsiwe S, Ndungu T, Modukanele M, Peter T, Novitsky V, Ndwapi N, Tendani G, Avalos A, Wester W, et al. Mutations and polymorphisms associated with antiretroviral drugs in HIV-1 C-infected african patients. Antivir Chem Chemother. 2004;15:189–200.

Article  CAS  PubMed  Google Scholar 

Ndung’u T, Gaseitsiwe S, Sepako E, Doualla-Bell F, Peter T, Kim S, Thior I, Novitsky VA, Essex M. Major histocompatibility complex class II (HLA-DRB and -DQB) allele frequencies in Botswana: association with human immunodeficiency virus type 1 infection. Clin Diagn Lab Immunol. 2005;12:1020–8.

PubMed  PubMed Central  Google Scholar 

Ndung’u T, Sepako E, McLane MF, Chand F, Bedi K, Gaseitsiwe S, Doualla-Bell F, Peter T, Thior I, Moyo SM et al. HIV-1 subtype C in vitro growth and coreceptor utilization. Virology 2006.

Novitsky V, Gilbert P, Peter T, McLane MF, Gaolekwe S, Rybak N, Thior I, Ndung’u T, Marlink R, Lee TH, Essex M. Association between virus-specific T-cell responses and plasma viral load in human immunodeficiency virus type 1 subtype C infection. J Virol. 2003;77:882–90.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shapiro RL, Ndung’u T, Lockman S, Smeaton LM, Thior I, Wester C, Stevens L, Sebetso G, Gaseitsiwe S, Peter T, Essex M. Highly active antiretroviral therapy started during pregnancy or postpartum suppresses HIV-1 RNA, but not DNA, in breast milk. J Infect Dis. 2005;192:713–9.

Article  CAS  PubMed  Google Scholar 

Burton DR, Desrosiers RC, Doms RW, Feinberg MB, Gallo RC, Hahn B, Hoxie JA, Hunter E, Korber B, Landay A, et al. Public health. A sound rationale needed for phase III HIV-1 vaccine trials. Science. 2004;303:316.

Article  CAS  PubMed  Google Scholar 

Madlala P, Singh R, An P, Werner L, Mlisana K, Abdool Karim SS, Winkler CA. Ndung’u T: association of polymorphisms in the Regulatory Region of the Cyclophilin a gene (PPIA) with gene expression and HIV/AIDS disease progression. J Acquir Immune Defic Syndr. 2016;72:465–73.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Naicker DD, Werner L, Kormuth E, Passmore JA, Mlisana K, Karim SA. Ndung’u T: Interleukin-10 promoter polymorphisms influence HIV-1 susceptibility and primary HIV-1 pathogenesis. J Infect Dis. 2009;200:448–52.

Article  CAS  PubMed  Google Scholar 

Reddy K, Ooms M, Letko M, Garrett N, Simon V, Ndung’u T. Functional characterization of vif proteins from HIV-1 infected patients with different APOBEC3G haplotypes. AIDS. 2016;30:1723–9.

Article  CAS  PubMed  Google Scholar 

Reddy K, Winkler CA, Werner L, Mlisana K, Abdool Karim SS, Ndung’u T. APOBEC3G expression is dysregulated in primary HIV-1 infection and polymorphic variants influence CD4 + T-cell counts and plasma viral load. AIDS. 2010;24:195–204.

Article  CAS  PubMed  Google Scholar 

Sewram S, Singh R, Kormuth E, Werner L, Mlisana K, Karim SS, Ndung’u T, Team CAIS. Human TRIM5alpha expression levels and reduced susceptibility to HIV-1 infection. J Infect Dis. 2009;199:1657–63.

Article  CAS  PubMed  Google Scholar 

Singh R, Patel V, Mureithi MW, Naranbhai V, Ramsuran D, Tulsi S, Hiramen K, Werner L, Mlisana K, Altfeld M, et al. TRIM5alpha and TRIM22 are differentially regulated according to HIV-1 infection phase and compartment. J Virol. 2014;88:4291–303.

Article  PubMed  PubMed Central  Google Scholar 

Wright JK, Brumme ZL, Carlson JM, Heckerman D, Kadie CM, Brumme CJ, Wang B, Losina E, Miura T, Chonco F, et al. Gag-protease-mediated replication capacity in HIV-1 subtype C chronic infection: associations with HLA type and clinical parameters. J Virol. 2010;84:10820–31.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wright JK, Naidoo VL, Brumme ZL, Prince JL, Claiborne DT, Goulder PJ, Brockman MA, Hunter E. Ndung’u T: impact of HLA-B*81-associated mutations in HIV-1 gag on viral replication capacity. J Virol. 2012;86:3193–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wright JK, Novitsky V, Brockman MA, Brumme ZL, Brumme CJ, Carlson JM, Heckerman D, Wang B, Losina E, Leshwedi M, et al. Influence of gag-protease-mediated replication capacity on disease progression in individuals recently infected with HIV-1 subtype C. J Virol. 2011;85:3996–4006.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barton JP, Rajkoomar E, Mann JK, Murakowski DK, Toyoda M, Mahiti M, Mwimanzi P, Ueno T, Chakraborty AK. Ndung’u T: modelling and in vitro testing of the HIV-1 Nef fitness landscape. Virus Evol. 2019;5:vez029.

Article  PubMed  PubMed Central  Google Scholar 

Ferguson AL, Mann JK, Omarjee S, Ndung’u T, Walker BD, Chakraborty AK. Translating HIV sequences into quantitative fitness landscapes predicts viral vulnerabilities for rational immunogen design. Immunity. 2013;38:606–17.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mann JK, Barton JP, Ferguson AL, Omarjee S, Walker BD, Chakraborty A, Ndung’u T. The fitness landscape of HIV-1 gag: advanced modeling approaches and validation of model predictions by in vitro testing. PLoS Comput Biol. 2014;10:e1003776.

Article  PubMed  PubMed Central  Google Scholar 

Koofhethile CK, Ndhlovu ZM, Thobakgale-Tshabalala C, Prado JG, Ismail N, Mncube Z, Mkhize L, van der Stok M, Yende N, Walker BD, et al. CD8 + T cell breadth and Ex vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without protective HLA class I alleles. J Virol. 2016;90:6818–31.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gounder K, Padayachi N, Mann JK, Radebe M, Mokgoro M, van der Stok M, Mkhize L, Mncube Z, Jaggernath M, Reddy T, et al. High frequency of transmitted HIV-1 gag HLA class I-driven immune escape variants but minimal immune selection over the first year of clade C infection. PLoS ONE. 2015;10:e0119886.

Article  PubMed  PubMed Central